Catabasis Pharmaceuticls Company Profile (NASDAQ:CATB)

About Catabasis Pharmaceuticls

Catabasis Pharmaceuticls logoCatabasis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted (SMART), a linker drug discovery platform. The SMART linker drug discovery platform enables to engineer product candidates that can modulate multiple targets in a disease. The Company's primary focus is on treatments for rare diseases. The Company is also developing other product candidates for the treatment of lipid disorders. The Company's CAT-1004 is a SMART linker conjugate of salicylate, a non-steroidal anti-inflammatory drug, and the omega-3 fatty acid docosahexaenoic acid (DHA), a naturally occurring unsaturated fatty acid with anti-inflammatory properties. Its CAT-2000 series product candidates inhibit the Sterol Regulatory Element Binding Protein (SREBP) pathway. The Company's CAT-4001 is a SMART linker conjugate of monomethyl fumarate and DHA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CATB
  • CUSIP:
Key Metrics:
  • Previous Close: $4.97
  • 50 Day Moving Average: $4.31
  • 200 Day Moving Average: $4.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.95
  • P/E Growth: 0.00
  • Market Cap: $76.91M
  • Outstanding Shares: 15,381,000
  • Beta: 2.07
Additional Links:
Companies Related to Catabasis Pharmaceuticls:

Analyst Ratings

Consensus Ratings for Catabasis Pharmaceuticls (NASDAQ:CATB) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.75 (357.75% upside)

Analysts' Ratings History for Catabasis Pharmaceuticls (NASDAQ:CATB)
Show:
DateFirmActionRatingPrice TargetDetails
8/12/2016WedbushReiterated RatingOutperform$17.00View Rating Details
6/8/2016Cowen and CompanyReiterated RatingBuyView Rating Details
5/25/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$28.00View Rating Details
3/22/2016Citigroup Inc.Lower Price TargetBuy$21.00 -> $16.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Catabasis Pharmaceuticls (NASDAQ:CATB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/11/2016Q216($0.65)($0.61)ViewListenView Earnings Details
5/12/2016Q1($0.64)($0.61)ViewListenView Earnings Details
3/4/2016Q415($0.69)($0.63)ViewListenView Earnings Details
11/12/2015Q315($0.64)($0.55)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Catabasis Pharmaceuticls (NASDAQ:CATB)
Current Year EPS Consensus Estimate: $-2.51 EPS
Next Year EPS Consensus Estimate: $-2.55 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.63)($0.60)($0.62)
Q2 20162($0.65)($0.61)($0.63)
Q3 20162($0.67)($0.61)($0.64)
Q4 20162($0.69)($0.61)($0.65)
Q1 20171($0.73)($0.73)($0.73)
Q2 20171($0.80)($0.80)($0.80)
Q3 20171($0.91)($0.91)($0.91)
Q4 20171($1.05)($1.05)($1.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Catabasis Pharmaceuticls (NASDAQ:CATB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Catabasis Pharmaceuticls (NASDAQ:CATB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/30/2015Medimmune Ventures, Inc.Major ShareholderBuy223,439$12.00$2,681,268.00View SEC Filing  
6/30/2015Nicholas GalakatosDirectorBuy376,695$12.00$4,520,340.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Catabasis Pharmaceuticls (NASDAQ:CATB)
DateHeadline
zacks.com logoMallinckrodt DMD Drug Gets Fast Track Status in the U.S. (NASDAQ:CATB)
www.zacks.com - August 26 at 12:08 PM
News IconStock Tracking Lower for the Quarter: Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) - Post News (NASDAQ:CATB)
www.kentuckypostnews.com - August 20 at 4:08 PM
News IconHow is the Crowd Rating Shares of Catabasis Pharmaceuticals Inc (NASDAQ:CATB)? - Post News (NASDAQ:CATB)
www.kentuckypostnews.com - August 20 at 9:02 AM
finance.yahoo.com logoCATABASIS PHARMACEUTICALS INC Financials (NASDAQ:CATB)
finance.yahoo.com - August 19 at 4:46 PM
News IconWhat are Analysts Expecting for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) Earnings? - Post News (NASDAQ:CATB)
www.kentuckypostnews.com - August 18 at 3:21 PM
News IconCatabasis Pharmaceuticals Inc (NASDAQ:CATB) Stock Update: Analysts & Crowd Update - Post News (NASDAQ:CATB)
www.kentuckypostnews.com - August 18 at 12:30 PM
insidermonkey.com logoWhat We’re Watching For In The Upcoming Catabasis Pharmaceuticals Inc (CATB) Data (NASDAQ:CATB)
www.insidermonkey.com - August 15 at 4:15 PM
kcregister.com logoBiotech Losers: ArQule Inc. (NASDAQ:ARQL), Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), XTL ... - KC Register (NASDAQ:CATB)
www.kcregister.com - August 15 at 11:19 AM
News IconCatabasis Pharmaceuticls Inc. (NASDAQ: CATB) Outperform rating reiterated at Wedbush - BNB Daily (blog) (NASDAQ:CATB)
www.baseball-news-blog.com - August 15 at 11:19 AM
marketexclusive.com logoWhat We’re Watching For In The Upcoming Catabasis Pharmaceuticals Inc (NASDAQ:CATB) Data (NASDAQ:CATB)
marketexclusive.com - August 12 at 4:04 PM
finance.yahoo.com logoEdited Transcript of CATB earnings conference call or presentation 11-Aug-16 8:30pm GMT (NASDAQ:CATB)
finance.yahoo.com - August 12 at 4:04 PM
nasdaq.com logoHealth Care Sector Update for 08/12/2016: ,CATB,PTX,XLV - Nasdaq (NASDAQ:CATB)
www.nasdaq.com - August 12 at 12:43 PM
sg.finance.yahoo.com logoCatabasis Pharmaceuticals posts 2Q loss (NASDAQ:CATB)
sg.finance.yahoo.com - August 11 at 9:55 PM
publicnow.com logoCatabasis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Corporate Highlights (NASDAQ:CATB)
www.publicnow.com - August 11 at 9:55 PM
biz.yahoo.com logoQ2 2016 Catabasis Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CATB)
biz.yahoo.com - August 11 at 12:21 PM
biz.yahoo.com logoCatabasis Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:CATB)
biz.yahoo.com - August 11 at 12:21 PM
businesswire.com logoCatabasis Pharmaceuticals to Present at 2016 Wedbush PacGrow Healthcare Conference - Business Wire (press release) (NASDAQ:CATB)
www.businesswire.com - August 9 at 5:11 PM
finance.yahoo.com logoCatabasis Pharmaceuticals to Present at 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:CATB)
finance.yahoo.com - August 9 at 12:59 PM
businesswire.com logoCatabasis Pharmaceuticals to Report Second Quarter 2016 Financial Results and Recent Corporate Developments on ... - Business Wire (press release) (NASDAQ:CATB)
www.businesswire.com - July 29 at 5:44 AM
News IconCatabasis Pharmaceuticals Inc Can't Be More Safe. Trades Significantly Higher - Press Telegraph (NASDAQ:CATB)
presstelegraph.com - July 23 at 8:22 AM
News IconTracking Analyst Ratings and Target Projections for: Catabasis Pharmaceuticals Inc (NASDAQ:CATB) - Press Telegraph (NASDAQ:CATB)
presstelegraph.com - July 21 at 8:28 AM
News IconStock Moving Lower for the Month; Investor Update on Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) - Engelwood Daily (NASDAQ:CATB)
www.engelwooddaily.com - July 21 at 8:28 AM
News IconCatabasis Pharmaceuticals Inc (NASDAQ:CATB): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CATB)
www.engelwooddaily.com - July 21 at 8:28 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) - TGP (NASDAQ:CATB)
telanaganapress.com - July 21 at 8:28 AM
News IconTrading Performance and Target Watch for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) - Press Telegraph (NASDAQ:CATB)
presstelegraph.com - July 18 at 4:14 PM
fiscalstandard.com logoCatabasis Pharmaceuticals, Inc. (CATB) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CATB)
www.fiscalstandard.com - July 17 at 3:54 PM
ftsenews.co.uk logoCatabasis Pharmaceuticals, Inc. (CATB) Updated Price Targets - FTSE News (NASDAQ:CATB)
www.ftsenews.co.uk - July 14 at 4:09 PM
News IconCatabasis Pharmaceuticals Incorporated (NASDAQ:CATB) Short Interest Increased By 2.74% - Consumer Eagle (NASDAQ:CATB)
www.consumereagle.com - July 14 at 4:09 PM
News IconCrowd Rating and Earnings Recap for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) - Telanagana Press (NASDAQ:CATB)
telanaganapress.com - July 14 at 4:09 PM
finance.yahoo.com logoCatabasis Pharmaceuticals Names Joseph Johnston VP, Regulatory Affairs (NASDAQ:CATB)
finance.yahoo.com - July 12 at 8:00 AM
finance.yahoo.com logoAdvicent introduces Narrator® Clients powered by NaviPlan® in its latest release (NASDAQ:CATB)
finance.yahoo.com - July 11 at 10:01 AM
finance.yahoo.com logoCatabasis Pharmaceuticals Announces the Initiation of an Open-Label Extension for the MoveDMD® Trial Studying ... - Yahoo Finance (NASDAQ:CATB)
finance.yahoo.com - July 7 at 11:55 AM
publicnow.com logoCatabasis Pharmaceuticals Announces the Initiation of an Open-Label Extension for the MoveDMD® Trial Studying Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy (NASDAQ:CATB)
www.publicnow.com - July 7 at 8:21 AM
finance.yahoo.com logo8:03 am Catabasis Pharmaceuticals announces initiation of open-label extension for the Phase 2 portion (Part B) of the MoveDMD trial studying edasalonexent in boys with Duchenne muscular dystrophy (NASDAQ:CATB)
finance.yahoo.com - July 7 at 8:03 AM
News IconShares Dropping Lower in Session: Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) - Telanagana Press (NASDAQ:CATB)
telanaganapress.com - July 6 at 8:52 AM
fiscalstandard.com logoCatabasis Pharmaceuticals, Inc. (CATB) Current Analyst Ratings - Fiscal Standard (NASDAQ:CATB)
www.fiscalstandard.com - July 6 at 8:52 AM
News IconCompany Stock Lower on the Week Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) - Engelwood Daily (NASDAQ:CATB)
www.engelwooddaily.com - July 3 at 8:46 AM
biz.yahoo.com logoCATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CATB)
biz.yahoo.com - July 1 at 4:18 PM
News IconTime to Buy Catabasis Pharmaceuticals Inc After Today's Huge Decline? - Engelwood Daily (NASDAQ:CATB)
www.engelwooddaily.com - July 1 at 4:04 PM
News IconCatabasis Pharmaceuticals Incorporated (NASDAQ:CATB) Sellers Increased By 2.74% Their Shorts - Engelwood Daily (NASDAQ:CATB)
www.engelwooddaily.com - June 29 at 9:07 PM
News IconShare Update and Earnings Review for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) - Press Telegraph (NASDAQ:CATB)
presstelegraph.com - June 28 at 8:34 PM
kcregister.com logoToday's Watch List: Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), Blue Capital Reinsurance Holdings Ltd. (NYSE ... - KC Register (NASDAQ:CATB)
www.kcregister.com - June 28 at 3:24 PM
News IconCatabasis Pharmaceuticals Inc (NASDAQ:CATB) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:CATB)
www.engelwooddaily.com - June 28 at 3:24 PM
News IconEquity Research and Technical Review on Catabasis Pharmaceuticals Inc (NASDAQ:CATB) - Press Telegraph (NASDAQ:CATB)
presstelegraph.com - June 28 at 3:24 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Catabasis Pharmaceuticals, Inc. (CATB) - Fiscal Standard (NASDAQ:CATB)
www.fiscalstandard.com - June 28 at 3:24 PM
biz.yahoo.com logoCATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:CATB)
biz.yahoo.com - June 20 at 4:02 PM
breakingfinancenews.com logoCatabasis Pharmaceuticals (NASDAQ:CATB) target price dropped to $8 as recorded today by Citigroup (NASDAQ:CATB)
breakingfinancenews.com - June 20 at 10:27 AM
finance.yahoo.com logoCatabasis Pharmaceuticals to Present Edasalonexent (CAT-1004), an Oral Agent Targeting NF-kB: MoveDMDSM Trial in Duchenne Muscular Dystrophy (DMD) at the 2016 PPMD Annual Connect Conference (NASDAQ:CATB)
finance.yahoo.com - June 20 at 8:00 AM
streetinsider.com logoCatabasis Pharma (CATB) Announces CAT-2054 Phase 2a Missed Primary Endpoint in Hypercholesterolemia (NASDAQ:CATB)
www.streetinsider.com - June 8 at 10:29 PM
schaeffersresearch.com logoDrug Data Deals a Blow to Catabasis Pharmaceuticals Inc (CATB) (NASDAQ:CATB)
www.schaeffersresearch.com - June 8 at 10:29 PM

Social

Catabasis Pharmaceuticls (NASDAQ:CATB) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff